Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	113.94	124.29	143.74	151.79	280.12	447.65
Short-Term Investments	542.83	657.04	606.35	847.12	677.95	230.42
Cash & Short-Term Investments	656.78	781.32	750.09	998.92	958.07	678.06
Cash Growth	-4.60%	4.16%	-24.91%	4.26%	41.30%	90.56%
Accounts Receivable	-	-	-	0.31	0.4	75
Other Receivables	-	-	-	4.91	4.54	7.65
Total Trade Receivables	-	-	-	5.22	4.94	82.65
Other Current Assets	23.62	27.88	20.02	15.37	13.23	9.39
Total Current Assets	680.39	809.2	770.1	1,020	976.24	770.1
Net Property, Plant & Equipment	46.19	57.67	68.87	75.39	27.32	28.83
Other Intangible Assets	-	2.3	2.3	2.3	2.3	-
Other Long-Term Assets	2.26	2.12	2.71	2.58	2.58	0.9
Total Assets	728.84	871.3	843.98	1,100	1,008	799.83
Accounts Payable	5.18	14.1	9.21	10.58	8.28	6.35
Accrued Expenses	23.22	21.24	14.89	22.7	13.56	5.76
Current Portion of Leases	3.53	5.73	4.96	4.28	1.84	1.52
Unearned Revenue	-	7.68	-	-	0.25	-
Other Current Liabilities	0.61	1.99	1.2	26.15	0.4	-
Total Current Liabilities	32.53	50.73	30.27	63.71	24.32	13.63
Long-Term Leases	30.66	42.78	48.5	53.47	21.06	22.9
Other Long-Term Liabilities	-	-	13.21	32.38	65.26	0
Total Long-Term Liabilities	30.66	42.78	61.71	85.84	86.31	22.9
Total Liabilities	63.18	93.5	91.98	149.55	110.64	36.54
Common Stock	0.17	0.17	0.13	0.12	0.11	0.09
Additional Paid-in Capital	2,551	2,517	2,153	2,019	1,667	1,167
Accumulated Other Comprehensive Income	-0.16	-0.99	-0.2	-10.42	-1.09	0.06
Retained Earnings	-1,886	-1,738	-1,401	-1,059	-768.1	-404.23
Total Common Shareholders' Equity	665.66	777.79	752	950.22	897.81	763.29
Shareholders' Equity	665.66	777.79	752	950.22	897.81	763.29
Total Liabilities & Equity	728.84	871.3	843.98	1,100	1,008	799.83
Total Debt	34.18	48.5	53.47	57.74	22.9	24.42
Net Cash (Debt)	622.59	732.82	696.62	941.18	935.17	653.64
Net Cash Growth	-15.04%	5.20%	-25.98%	0.64%	43.07%	97.48%
Net Cash Per Share	3.84	5.13	5.68	8.39	9.83	15.34
Book Value	665.66	777.79	752	950.22	897.81	763.29
Book Value Per Share	4.11	5.44	6.13	8.47	9.44	17.91
Tangible Book Value	665.66	775.49	749.7	947.92	895.51	763.29
Tangible Book Value Per Share	4.11	5.43	6.12	8.45	9.41	17.91

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q